ORGS's logo.
Ticker Symbol: ORGS

Orgenesis Inc

$3.87 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001460602

Company Profile

Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensedPOCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 20271 Goldenrod Ln
CEO: Vered Caplan
Tags:
  • Health Technology
  • Biotechnology

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.62
Change: $0.00 ( 0.32%)
Days Range: $0.58 - $0.64
Beta: 0.81
52wk. High: $2.64
52wk. Low: $0.38
Ytd. Change -67.98%
50 Day Moving Average: $0.72
200 Day Moving Average: $1.02
Shares Outstanding: 28466807

Valuation

Market Cap: 1.8B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A